Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes

Hideya Mizuno, Yong Yeon Cho, Wei-Ya Ma, Ann M. Bode, Zigang Dong

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

We previously reported data regarding the mechanism of neoplastic transformation in JB6 Cl41 mouse skin epidermal cells. However, experimental in vitro models for studying neoplastic transformation of human cells could provide further insight into the mechanisms of human cancer development. In this study, we have established a neoplastic transformation model with HaCaT cells, a human keratinocyte cell line, and showed the usefulness of this cell line for studying the mechanisms of neoplastic transformation. Epidermal growth factor (EGF) treatment induced a dose-dependent anchorage-independent cell transformation in HaCaT cells. Furthermore, PD98059, a mitogen-activated protein (MAP) kinase/ERK kinase (MEK) inhibitor, or SP600125, c-Jun N-terminal kinase (JNK) inhibitor, decreased cell growth, EGF-induced DNA synthesis and transformation. Unlike observations in the JB6 mouse epidermal cell model, SB203580, a stress-activated protein kinase-2/p38 α and β (p38) inhibitor, increased EGF-induced transformation in HaCaT cells. These results suggest that extracellular-signal regulated kinase (ERK), JNK, or p38 are implicated in EGF-induced neoplastic transformation of human cells.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalMolecular Carcinogenesis
Volume45
Issue number1
DOIs
StatePublished - Jan 2006

Keywords

  • Cell transformation
  • EGF
  • Human keratinocyte
  • MAP kinase

Fingerprint

Dive into the research topics of 'Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes'. Together they form a unique fingerprint.

Cite this